Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy

Blood-Brain Barrier (BBB) acts as a highly impermeable barrier, presenting an impediment to the crossing of most classical drugs targeted for neurodegenerative diseases including Parkinson's disease (PD). About the nature of drugs and other potential molecules, they impose unavoidable dose-rest...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatri, Dharmendra K., Preeti, Kumari, Tonape, Shivraj, Bhattacharjee, Sheoshree, Patel, Monica, Shah, Saurabh, Singh, Pankaj K., Srivastava, Saurabh, Gugulothu, Dalapathi, Vora, Lalitkumar, Singh, Shashi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Medicine, Neurology, Pharmacology, Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207920/
https://www.ncbi.nlm.nih.gov/pubmed/35524671
http://dx.doi.org/10.2174/1570159X20666220507022701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207920/
https://www.ncbi.nlm.nih.gov/pubmed/35524671
http://dx.doi.org/10.2174/1570159X20666220507022701

Ejemplares similares